Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
about
Impact of donor and recipient single nucleotide polymorphisms of IL28B rs8099917 in living donor liver transplantation for hepatitis CEarly trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival.Management of recurrent hepatitis C following liver transplantation.Antiviral treatment for hepatitis C virus infection after liver transplantation.The impact of sirolimus on hepatitis C recurrence after liver transplantation.The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantationNK cells, innate immunity and hepatitis C infection after liver transplantation.Living-donor liver transplantation and hepatitis CRisk factors for hepatitis C recurrence after liver transplantation.Survival after liver transplantation for hepatitis C is unchanged over two decades in Canada.Liver transplantation for liver disease caused by hepatitis C virus infection.Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation.The impact of hepatitis C burden: an evidence-based approach.Recurrent HCV after liver transplantation-mechanisms, assessment and therapy.A retrospective 15-year review: survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.Treatment of Hepatitis C Virus Infection in Liver Transplant Recipients.Effect of tacrolimus on survival in hepatitis C-infected patients after liver transplantation.Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey.Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients.Improving graft survival for patients undergoing liver transplantation.Assessing uncertainty in the burden of Hepatitis C Virus: comparison of estimated disease burden and treatment costs in the UK.Liver transplantation and hepatitis C
P2860
Q31153267-D46C5E86-EE35-41B9-A346-3F2A8E9BCBE7Q34046222-51E73CD4-7C8D-4EF7-97F0-57B68EADB854Q34298333-920D8652-3037-460F-9F4D-327E8EC1B829Q34340293-036CF366-0F91-4C0F-906A-F72FEBA24D5EQ34522556-62837C11-0FAF-4568-BB67-47FD98813F09Q34575747-90DB53EA-1EC4-4887-99E2-E8CB0A70FEB8Q35019869-27998737-11C7-4BD1-B34F-221B361DEAB7Q36587253-31F7CC5B-884E-4B2B-B8C4-FB11647B60EAQ36980754-3B6F017D-979B-4545-A312-4BE4072D020BQ37136580-8F912063-4072-4761-A9A9-B2E72D997C4EQ37396780-0E038AD5-B79F-4473-BEAA-C19A907768CBQ37628365-3E58667A-1967-4152-96A4-97539A68C9F5Q37973516-841DAF5D-AF7F-4CC7-A548-09A4C7CE3F63Q38181631-94C67878-6A3E-4E0D-B398-24E25BC5E878Q38229320-3787CAD2-1381-4B0D-A875-FBDC0E1A71D8Q38286355-62B6015E-750D-46FF-BD65-E9E19B15D6C3Q38872799-0D35CD6F-397F-47AA-9F5F-3852B8394D4DQ42028499-7657B064-83B9-4ED3-8E76-C521C4B3A312Q42227943-D30FCD5D-4398-47CB-AA46-3D03201B3B54Q42977889-303BA58B-A219-4F9B-9051-C3E6BB59618CQ43035412-48715942-E91E-44CE-9DD4-31C19F250D37Q47560957-352A2856-E571-40A8-96F1-F4167C5614E0Q58704499-553208BB-12A5-4B48-A174-70423D768AB8
P2860
Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Trends in post-liver transplan ...... and 2001 in the United States.
@en
Trends in post-liver transplan ...... and 2001 in the United States.
@nl
type
label
Trends in post-liver transplan ...... and 2001 in the United States.
@en
Trends in post-liver transplan ...... and 2001 in the United States.
@nl
prefLabel
Trends in post-liver transplan ...... and 2001 in the United States.
@en
Trends in post-liver transplan ...... and 2001 in the United States.
@nl
P2093
P356
P1476
Trends in post-liver transplan ...... and 2001 in the United States.
@en
P2093
Dorry L Segev
Hwan Y Yoo
Karen L Krok
Paul J Thuluvath
P304
P356
10.1002/LT.21123
P577
2007-05-01T00:00:00Z